Searched for
BUY SUN PHARMA
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- From Adani Green to Tata Tech: 50 companies swing back to profit in Q4 despite market turmoilIndian companies show strong recovery. Over 50 firms moved from losses to profits in the March quarter. This turnaround happened despite ma...
- Why market rallied today? Sensex jumps 1,074 points, Nifty closes above 24,000. 5 factors behind surgeIndian stock markets surged on Monday, with Sensex and Nifty rallying over 1% each, driven by rising hopes of a US-Iran peace deal and fall...
- Buy, Sell or Hold: Citi maintains buy on Eicher Motors; Goldman Sachs retains buy on Max HealthcareBrokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospect...
- Ahead of Market: 10 things that will decide stock market action on MondayIndian equity benchmarks closed modestly higher on Friday, with financial stocks leading the gains. The Nifty and Sensex edged up, though p...
- 6 pharma stocks that Bernstein sees up to 40% upside potential. Do you own any?Bernstein initiated coverage on six pharma stocks, expressing a positive outlook on the Indian healthcare sector driven by AI, innovation i...
- Market wrap: Sensex rises 232 points, Nifty closes above 23,700 as rupee recovers from lifetime lowsIndian markets ended the week higher after recovering intraday volatility, with Sensex and Nifty posting modest gains amid hopes of easing ...
- Bank Nifty near key resistance zone; breakout above 54,300 crucial: Ajit MishraIndian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank Nifty showing relative streng...
- Sensex drops 114 points, Nifty below 23,650 as rupee hits fresh lifetime low; broader markets outperformIndian markets ended lower on Tuesday as Sensex and Nifty erased early gains amid rupee weakness, even as volatility cooled. IT stocks outp...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...
- Markets rebound sharply: Sensex recovers 1,100 points from day’s low, Nifty closes near 23,650Sensex rose 1,100 points from its day’s low to close at 75,315, and Nifty 50 gained 333 points from its day’s low to end the session at 23,...
- Selling at higher levels turns 23,800 into key barrier for Nifty: AnalystsBenchmark Nifty closed lower last week. Analysts anticipate continued range-bound trading for Nifty this week. Trading strategies suggest b...
- Stock Radar: Sun Pharma breaks out from falling trendline resistance to hit fresh 52-week high; time to buy?Sun Pharmaceutical Industries Ltd has broken out from a falling trendline resistance on weekly charts, hitting a fresh 52-week high. Expert...
- Pharma, NBFCs see fresh mutual fund buying in AprilIndian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...
- Sensex rises 50 points, Nifty closes above 23,400 as markets snap 4-session losing streak; metal stocks shineIndian stock markets ended in the green, with Sensex and Nifty snapping a four-session losing streak. This occurred despite the rupee hitti...
- Jio Financial, ITC Hotels and Manappuram Finance among stocks bought and sold by mutual funds in AprilMutual funds injected Rs 30,600 crore into Indian equities in April, with significant buying in ICICI Bank, SBI, and Sun Pharma. Key reduct...
- Buy capital goods on dips, stay cautious on IT and consumption: Sudip BandyopadhyayMarket expert Sudip Bandyopadhyay outlines investment strategies across key sectors. He sees opportunities in State Bank of India and a gen...
- Stocks to buy in 2026 for long term: Varun Beverages, Sun Pharma among 5 stocks that could give 10-20% returnWe have collated a list of recommendations from top brokerage firms from ETNow and other sources
Load More
